Literature DB >> 27312859

The anti-estrogenic activity of indole-3-carbinol in neonatal rat osteoblasts is associated with the estrogen receptor antagonist 2-hydroxyestradiol.

J Enríquez1, R Velázquez-Cruz2, A Parra-Torres2, R Gutiérrez-Sagal3, F Larrea4.   

Abstract

PURPOSE: To gain new insight into the roles of cruciferous vegetable-derived bioactive phytochemicals in bone cells, we investigated the effects of indole-3-carbinol (I3C) on cell proliferation and differentiation in estradiol (E2)-exposed calvarial osteoblasts that were obtained from neonatal rats.
METHODS: Osteoblast activity was assessed by analyzing cellular DNA, cell-associated osteocalcin (OC) levels and alkaline phosphatase (AP) activity. We also examined [(3)H]-estrone (E1) metabolism and estrogen-agonistic and estrogen-antagonistic activities of 2-hydroxy (OH) E1 and 2-OHE2 and their capacity to displace [(3)H]-E2 at ER binding sites using competition studies.
RESULTS: I3C did not affect on cellular DNA, OC levels or AP activity. However, I3C completely inhibited E2-induced increases in cell proliferation and differentiation in neonatal rat osteoblasts. Metabolic studies demonstrated that I3C promoted the conversion of [(3)H]-E1 to 2-OHE1 and 2-OHE2 and those higher rates of conversion (twofold-threefold) were archived when a higher dose of I3C was applied. Proliferation and differentiation studies showed that 2-OHE2 but not 2-OHE1 inhibited E2-induced increases in cell proliferation and differentiation via an ER-mediated mechanism. Likewise, Esr1 was expressed at high level than Esr2. 2-OHE1 showed no activity or affinity for ER.
CONCLUSIONS: This study is the first to show that a bioactive compound derived from cruciferous vegetables, I3C, abolishes the E2-mediated stimulation of cell activities including, proliferation and differentiation, in rat osteoblasts and increases the 2-hydroxylation of E1, resulting in the formation of inactive and anti-estrogenic metabolites. These results suggest that in neonatal rat osteoblasts, the anti-estrogenic effect of I3C is mediated by 2-OHE2 through ER-α.

Entities:  

Keywords:  Estrogen metabolites; Indole-3-carbinol; Osteoblast 2-hydroxylation; Osteoblasts differentiation; Osteoblasts proliferation

Mesh:

Substances:

Year:  2016        PMID: 27312859     DOI: 10.1007/s40618-016-0494-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.

Authors:  M Gupta; A McDougal; S Safe
Journal:  J Steroid Biochem Mol Biol       Date:  1998-12       Impact factor: 4.292

2.  Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone.

Authors:  Pyotr Kisselev; Wolf-Hagen Schunck; Ivar Roots; Dieter Schwarz
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

3.  The affinity of catechol estrogens for estrogen receptors in the pituitary and anterior hypothalamus of the rat.

Authors:  I J Davies; F Naftolin; K J Ryan; J Fishman; J Siu
Journal:  Endocrinology       Date:  1975-09       Impact factor: 4.736

4.  Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.

Authors:  S Lotinun; K C Westerlind; R T Turner
Journal:  J Endocrinol       Date:  2001-07       Impact factor: 4.286

5.  Altered hydroxylation of estrogen in patients with postmenopausal osteopenia.

Authors:  S K Lim; Y J Won; J H Lee; S H Kwon; E J Lee; K R Kim; H C Lee; K B Huh; B C Chung
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

6.  Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.

Authors:  J M Janssen; R Bland; M Hewison; M W Coughtrie; S Sharp; J Arts; H A Pols; J P van Leeuwen
Journal:  J Cell Biochem       Date:  1999-12-01       Impact factor: 4.429

7.  The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss.

Authors:  R Leelawattana; K Ziambaras; J Roodman-Weiss; C Lyss; D Wagner; T Klug; R Armamento-Villareal; R Civitelli
Journal:  J Bone Miner Res       Date:  2000-12       Impact factor: 6.741

8.  Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice.

Authors:  H L Bradlow; J Michnovicz; N T Telang; M P Osborne
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

9.  Human cementum tumor cells have different features from human osteoblastic cells in vitro.

Authors:  H Arzate; M A Alvarez-Pérez; M E Aguilar-Mendoza; O Alvarez-Fregoso
Journal:  J Periodontal Res       Date:  1998-07       Impact factor: 4.419

10.  Bioconversion of norethisterone, a progesterone receptor agonist into estrogen receptor agonists in osteoblastic cells.

Authors:  Ana E Lemus; Juana Enríquez; Angeles Hernández; René Santillán; Gregorio Pérez-Palacios
Journal:  J Endocrinol       Date:  2008-11-13       Impact factor: 4.286

View more
  1 in total

1.  Current results on the biological and pharmacological activities of Indole-3-carbinol.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2018-02-06       Impact factor: 4.068

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.